Brain scans could unlock the hidden timeline of Alzheimer's

NCT ID NCT07758660

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Patrick Lao Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study uses PET imaging to measure two key proteins in the brain—amyloid and tau—that are hallmarks of Alzheimer's disease. Researchers will follow 120 participants over five years, including people with normal aging, mild cognitive impairment, and dementia, to see how these protein levels change over time. The goal is to better understand the progression of Alzheimer's and potentially improve early detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PET imaging tracers: 18F-MK6240 (for tau) and 18F-Florbetaben (for amyloid)
What this could lead to
If successful, this could improve early detection and tracking of Alzheimer's disease, potentially leading to better diagnostic tools and treatment monitoring.
What could go wrong
This is an observational imaging study, not a treatment trial, so it won't directly test a therapy. The results may not immediately change clinical practice, and the imaging techniques may have limitations in accuracy or generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Columbia University Irving Medical Center

    New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.